Biggest News Aggregation in the World
📰 Technology Access Pool News

Page 13 - Technology Access Pool News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Technology Access Pool. Real-time updates on events, politics, business and more.

UNAIDS welcomes the first WHO COVID-19 Technology Access Pool licensing agreement

UNAIDS welcomes the first licensing agreement under the World Health Organization (WHO) COVID-19 Technology Access Pool (C-TAP) initiative, negotiated between Consejo Superior de Investigaciones Científicas (Spain’s High Council of Scientific Research) and the Medicines Patent Pool.
Costa Rica Winnie Byanyima Steering Committee Spain High Council Of Scientific Research World Health Organization Technology Access Pool
Source: unaids.org

Global licence deal to provide COVID antibody test tech free to poorer countries - WHO

A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and middle-income countries under a first of its kind agreement to boost production, the World Health Organisation said on Tuesday.
Nick Macfie Tedros Adhanom Ghebreyesus Stephanie Nebehay Thomson Reuters Trust Principles Technology Access Pool Spanish National Research Council

Spanish researchers open up Covid antibody tests tech

GENEVA: Spain’s top research institution reached a licensing deal Tuesday that paves the way for its Covid-19 antibody test to be produced more cheaply in developing countries. The World Health Organization (WHO) described the accord as the first transparent, global, non-exclusive license for a Covid-19 health tool that will help correct “devastating global inequity.” The deal
Costa Rica Costa Rican Carlos Alvarado Tedros Adhanom Ghebreyesus Rosa Menendez World Health Organization

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Global licence deal to provide Covid antibody test tech free to poorer countries: WHO

The existing four tests, which check for the presence of SARS-CoV-2 antibodies developed after either an infection or a vaccine dose, could also inform decisions on the need for boosters to protect against the disease.
Tedros Adhanom Ghebreyesus Technology Access Pool Roche Holding Spanish National Research Council World Health Organisation Patent Pool

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science